Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peerless Homeopathic appears to have been a small U.S. homeopathic product labeler and marketer rather than a conventional biotech or pharmaceutical developer. Publicly visible FDA/DailyMed and NDC records associate the name with consumer homeopathic tablet products such as Tinnistop and DriNites, and identify the business as "Wayne Josephson dba Peerless Homeopathic." The company does not appear to have an R&D pipeline, clinical-stage drug development programs, or a proprietary therapeutic platform typical of biotech companies. Available evidence suggests it marketed unapproved homeopathic OTC products for symptom relief, with manufacturing/registration activities involving Apotheca Company. Product listing records indicate that at least some marketed products became inactive or expired by 2024, so the business appears inactive based on currently visible public records.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peerless Homeopathic.